GlassScriptPhysician profile
Daniel A Sapeika
NPI 1043463110
$7,768.79
in general payments reported to CMS, 2019-2025
24 companies · $1,493 in 2025
The $1,493 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $221 · 2021: $759 · 2022: $1,063 · 2023: $1,005 · 2024: $3,001 · 2025: $1,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,388 · Travel and Lodging: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,387.66 |
| Travel and Lodging | $1,111.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,370.47 | 2019-2024 | Senza |
| Abbott Laboratories | $2,287.24 | 2021-2025 | Proclaim |
| Medtronic, INC. | $955.31 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Spr Therapeutics, INC | $509.97 | 2021-2025 | Sprint Pns System |
| Mml US, INC. | $265.28 | 2023 | Reactiv8 |
| Vertos Medical, INC. | $233.82 | 2023-2024 | Mild Device Kit |
| Boston Scientific Corporation | $230.54 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Curonix LLC | $206.91 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $162.36 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.62 | 2019-2020 | |
| Grt US Holding, INC. | $116.67 | 2022 | |
| Pfizer INC. | $49.29 | 2019 | |
| Collegium Pharmaceutical, INC. | $45.17 | 2019-2020 | |
| Averitas Pharma INC. | $27.52 | 2024 | Qutenza |
| Stryker Corporation | $24.88 | 2025 | Spinejack |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $24.20 | 2020 | |
| Saluda Medical Americas, INC. | $19.63 | 2025 | Evoke |
| Nalu Medical, INC. | $19.43 | 2024 | Nalu Neurostimulation System |
| Bioventus LLC | $19.23 | 2020 | |
| Lilly USA, LLC | $17.73 | 2020 | |
| Medtronic USA, INC. | $15.08 | 2019 | |
| Stimwave Technologies Incorporated | $13.78 | 2019 | |
| Mdd US Operations, LLC | $11.36 | 2019 | |
| Biodelivery Sciences International, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sapeika listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.